▼ SELL
10b5-1 Plan
$ Value
$387K
Shares
817
Price
$474
Filed
Feb 19
Insider
Name
Atkinson Edward Morrow III
Title
EVP, Chief Technical Ops. Off.
CIK
0001914164
Roles
Officer
Transaction Details
Transaction Date
2026-02-18
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
20,727
Footnotes
Restricted stock unit award that vests in installments beginning on February 20, 2027. | Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 08/11/2025.
Filing Info
Atkinson Edward Morrow III's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-25 | VRTX | ▼ | $325K |
| 2026-02-24 | VRTX | F | $789K |
| 2026-02-18 | VRTX | ▼ | $387K |
| 2026-02-17 | VRTX | A | $0 |
| 2026-02-17 | VRTX | F | $740K |
| 2026-02-17 | VRTX | ▼ | $994K |
| 2026-02-13 | VRTX | F | $928K |
| 2026-02-11 | VRTX | ▼ | $806K |
| 2026-02-10 | VRTX | F | $408K |
| 2026-01-22 | VRTX | A | $0 |
Other Insiders at VRTX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| SACHS BRUCE I | — | — | 2026-04-15 |
|
WAGNER CHARLES F JR
EVP, CO & FO
|
— | — | 2026-02-24 |
|
LEIDEN JEFFREY M
Executive Chairman
|
— | — | 2026-02-24 |
| Garber Alan M | — | — | 2026-04-15 |
|
Sachdev Amit
EVP Chief Patient & Ext Af Off
|
— | $28.4M | 2026-02-25 |
| Upadhyay Suketu | — | — | 2026-04-15 |
|
ALTSHULER DAVID
EVP, Chief Scientific Officer
|
— | — | 2026-01-22 |
| Bhatia Sangeeta N. | — | $133K | 2026-02-13 |
|
Kewalramani Reshma
CEO & President
|
— | — | 2026-02-24 |
|
Biller Jonathan
EVP and Chief Legal Officer
|
— | $3.6M | 2026-02-25 |
|
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
|
— | $1.6M | 2026-02-25 |
|
Bozic Carmen
EVP and CMO
|
— | $2.2M | 2026-03-27 |
|
Liu Joy
EVP and Chief Legal Officer
|
— | $439K | 2026-04-01 |
|
Ambrose Kristen
SVP & Chief Accounting Officer
|
— | $2.0M | 2026-02-26 |
|
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
|
— | $2.1M | 2026-02-25 |
|
McKechnie Duncan
EVP, Chief Commercial Officer
|
— | $2.4M | 2026-02-25 |
|
Bunnage Mark E.
EVP, Chief Scientific Officer
|
— | $3.0M | 2026-02-25 |